WHO Model List of Essential In Vitro Diagnostics
Found 19 recommendations
for 16 in vitro diagnostics
Download
-
Combined Mycobacterium tuberculosis nucleic acid amplification test and rifampicin and isoniazid resistance detection
Combined Mycobacterium tuberculosis nucleic acid amplification test and rifampicin and isoniazid resistance detectionTuberculosis (TB)SettingLaboratoryAssay format -
Combined Mycobacterium tuberculosis nucleic acid amplification test and rifampicin resistance detection
Combined Mycobacterium tuberculosis nucleic acid amplification test and rifampicin resistance detectionHIV infection, Meningitis, Tuberculosis (TB)SettingLaboratoryAssay format -
Culture-based drug susceptibility testing of antituberculosis drugs
Solid medium (Löwenstein–Jensen medium, Middlebrook 7H10 or 7H11 agar media)Culture-based drug susceptibility testing (DST) of antituberculosis drugsTuberculosis (TB)SettingLaboratoryAssay format -
Culture-based drug susceptibility testing of antituberculosis drugs
Liquid mediumCulture-based drug susceptibility testing (DST) of antituberculosis drugsTuberculosis (TB)SettingLaboratoryAssay format -
Interferon-gamma release assay
Interferon-gamma release assay (IGRA)Tuberculosis (TB)SettingLaboratoryAssay format -
Lipoarabinomannan antigen
Lipoarabinomannan (LAM) antigenHIV infection, Tuberculosis (TB)SettingNon-laboratoryAssay format -
Mycobacterial culture
Solid medium (Löwenstein–Jensen medium, Middlebrook 7H10 or 7H11 agar media). WHO recommended in 2025 WRDs (molecular techniques) -
Mycobacterial culture
Liquid medium -
Mycobacterium tuberculosis nucleic acid amplification test
Mycobacterium tuberculosis nucleic acid amplification testHIV infection, Tuberculosis (TB)SettingLaboratoryAssay formatSettingLaboratoryAssay format -
Nucleic acid amplification test for detection of TB drugs resistance
Nucleic acid amplification test for detection of TB drug resistanceTuberculosis (TB)SettingLaboratoryAssay format -
Nucleic acid amplification test for detection of TB drugs resistance
First-line drug LPAs and second-line drug LPAsNucleic acid amplification test for detection of TB drug resistanceTuberculosis (TB)SettingLaboratoryAssay format -
Nucleic acid amplification test for pyrazinamide resistance detection
Nucleic acid amplification test for pyrazinamide resistance detectionTuberculosis (TB)SettingLaboratoryAssay format -
Nucleic acid amplification test for rifampicin and isoniazid resistance detection
Nucleic acid amplification test for rifampicin and isoniazid resistance detectionTuberculosis (TB)SettingLaboratoryAssay format -
Nucleic acid amplification test for rifampicin resistance detection
Nucleic acid amplification test for rifampicin resistance detectionTuberculosis (TB)SettingLaboratoryAssay format -
Targeted next-generation sequencing for detection of TB drug resistance
Targeted NGS end-to-end solutions recommended for the detection of resistance to specific anti-TB agents can be found in the targeted NGS section within the 2025 WHO operational handbook on tuberculosis. Module 3: diagnosis available at https://iris.who.int/handle/10665/382121Targeted next-generation sequencing for detection of TB drug resistanceTuberculosis (TB)SettingLaboratoryAssay format -
Tuberculin skin test
This is not an IVD test